The U.S. Food and Drug Administration (FDA) approved a new drug April 2, 2021 for treatment of the fraudulent “disease” Attention Deficit Hyperactivity Disorder (ADHD) in children ages 6 to 17.
Like many other psychiatric drugs, this one also carries an FDA warning:”Qelbree may increase suicidal thoughts and actions in some children with ADHD, especially within the first few months of treatment or when the dose is changed.”
Qelbree (generic viloxazine hydrochloride) is a non-stimulant drug, although it is a Selective Norepinephrine Reuptake Inhibitor (sNRI), which means that it is really an antidepressant and is similar in operation to other ADHD drugs such as Strattera. The bottom line is that this class of drugs messes with neurotransmitters in the brain, and taking them is playing Russian Roulette with your brain.
Qelbree is an inhibitor of several Cytochrome P450 enzymes, which may intensify the drug’s side effects especially in combination with certain other drugs.
And again, like other similar psychiatric drugs, “The mechanism of action of viloxazine in the treatment of ADHD is unclear.“
There is no valid ADHD clinical test for children. There is no valid ADHD clinical test for adults. The ADHD diagnosis does not identify a genuine biological or psychological disorder. The diagnosis is simply a list of behaviors that may appear disruptive or inappropriate, and is essentially just an opinion.
No one denies that people can have difficult problems in their lives, that at times they can be mentally unstable, subject to unreasonable depression, anxiety or panic. Mental health care is therefore both valid and necessary.
However, the emphasis must be on workable mental healing methods that improve and strengthen individuals and thereby society by restoring people to personal strength, ability, competence, confidence, stability, responsibility and spiritual well-being. Psychiatric drugs and psychiatric treatments are not workable.
